mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.04 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.04 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.04 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.13 |
0.05 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.05 |